Aldeyra Therapeutics, Inc. (ALDX)
1.74
+0.02
(+1.16%)
USD |
NASDAQ |
May 06, 16:00
1.74
0.00 (0.00%)
After-Hours: 07:02
Aldeyra Therapeutics Cash from Financing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 15.71M |
| Rhythm Pharmaceuticals, Inc. | -5.40M |
| Pfizer Inc. | -2.856B |
| AbbVie, Inc. | -- |
| Glaukos Corp. | 15.77M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.299M |
| Cash from Investing (Quarterly) | 16.00M |
| Free Cash Flow | -33.35M |
| Free Cash Flow Per Share (Quarterly) | -0.0881 |
| Free Cash Flow to Equity (Quarterly) | -5.286M |
| Free Cash Flow to Firm (Quarterly) | -4.824M |
| Free Cash Flow Yield | -31.91% |